2025 · 2nd Quarter (Apr 1 - June 30)
Filed by AVENUE SOLUTIONS.
Open official filingSource-reported fields
Literal source text
Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; H.R. 946/S. 1862, ORPHAN Cures Act; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R.4299, Protecting Patient Access to Cancer and Complex Therapies Act
Literal federal measure citations: H.R. 946, S. 1862, H.R.4299
Issues related to 340b drug pricing program; Health care issues in H.R.1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21);
Literal federal measure citations: H.R.1, H. Con. Res. 14
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
